[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"model\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:model":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100376765",false,"NCT04185779","COLO-COHORT (Colorectal Cancer Cohort) Study","Inclusion Criteria:\n\nGroup A\n\n* Aged ≥30 years\\* and able to give informed consent\n* Patients attending colonoscopy\n\n  * Through Bowel Cancer Screening Programme (FIT positive, Bowelscope conversion, surveillance)\n  * Through standard NHS care (most commonly due to iron deficiency anaemia, altered bowel habit, weight loss, rectal bleeding, planned polypectomy\\*\\*, those referred on basis of family history, abnormal cross-sectional imaging, polyp surveillance or post CRC surveillance)\n\n    * The age of 30 was chosen to ensure that this is a population likely to be enriched for colorectal neoplasia with neoplasia below this age uncommon \\*\\*In those attending for planned polypectomy, the results from the initial colonoscopy and the endoscopy where the polypectomy is undertaken will be summated for purposes of calculating the neoplasia profile\n\n(COLO-SPEED) Group B\n\n* Any patient attending for colonoscopy and able to give informed consent\n* ≥ 18 years old\n* Patient from the North of England\n\nExclusion Criteria:\n\nGroup A\n\n* Unable to give informed consent\n* Known polyposis syndrome\n* Previous total colectomy\n* Known colonic stricture which would limit complete colonoscopy\n* Attending for planned therapeutic procedure other than polypectomy, such as insertion of colonic stent\n* Attending for assessment of known inflammatory bowel disease (IBD) activity or for IBD surveillance\n* Patients currently recruited into an interventional CTIMP for CRC prevention\\*\n\nCOLO-SPEED (Group B) \\*\\*\n\n* Unable to give informed consent\n* Not in a centre supported by COLO-SPEED infrastructure (North of England)","ALL","18 Years",{"count":17,"type":18},15000,"ESTIMATED","OBSERVATIONAL","This is a cross-sectional study aimed at identifying factors which best predicts patients at high risk of colorectal cancer or colorectal adenomas and to develop a risk prediction model.",[22,23,24,25,26],"Colorectal Cancer","Colorectal Adenoma","Colorectal Neoplasm","Predictive Cancer Model","Model","RECRUITING","2020-10-19",{"date":30,"type":31},"2020-10-22","ACTUAL",{"date":33,"type":31},"2019-12-13",{"date":35,"type":18},"2026-08-15",{"name":37,"class":38},"South Tyneside and Sunderland NHS Foundation Trust","OTHER",3,""]